Hanbang Technology: Shareholders holding more than 5% reduced their holdings by 114,355 shares, triggering a 1% change in equity.

Hanbang Technology announced that on August 3, 2026, its shareholder, Shanghai WuXi AppTec New Drug Development Co., Ltd., reduced its stake by 114,355 shares through a centralized bidding trading method, accounting for 0.1% of the company's total equity. After this change in equity, its shareholding ratio decreased from 6.04% to 5.94%, touching the 1% threshold. This reduction is in line with the previously disclosed plan and has not yet been fully executed. It will not result in a change in the controlling shareholder or the actual controller, and there will be no significant impact on the company.